logo
Sign in

TARO Stock Price, Chart, Stats & News

Taro Pharmaceutical Industries Ltd.
Save
1.62B
Market cap
30.05x
Current P/E
Forward P/E

TARO chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
48.47%
Operating margin
3.42%
Pretax margin
13.14%
Net margin
8.56%
Effective tax rate
34.84%
ROA
2.49%
ROE
3.06%
D/E
Interest coverage ratio

TARO valuation

P/E
30.05x
P/S
2.57x
P/B
0.90x
P/CF
12.20x
P/FCF
20.66x
P/OCF
12.20x
PEG
0.30x
EV multiple
51.51x

About

Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products.

Similar securities

Based on sector and market capitalization

Report issue